Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | -1.37% | -1.10% | -18.04% |
09/05 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.04% | 92.22M | |
+15.79% | 78.22B | |
+8.25% | 8.84B | |
-12.05% | 5.07B | |
+53.66% | 4.82B | |
+11.63% | 4.2B | |
+9.79% | 2.28B | |
-23.67% | 2.28B | |
+21.04% | 2.2B | |
-32.35% | 2.12B |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- B. Riley Trims Eton Pharmaceuticals' Price Target to $9 from $10 But Notes 'Solid' Growth Prospects Despite Partner Setback, Keeps Buy Rating